Showing results (1601-1610 of 2,048) with videos related to

Sort By:
Pageof 205
Intensive Care Medicine|February 20, 2020
Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists WorkshopMichael O Harhay, Jonathan D Casey, Marina Clement, et al.
British Journal of Haematology|June 22, 2019
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicityToby A Eyre, Amy A Kirkwood, Julia Wolf, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
Journal of Cardiac Failure|August 1, 2009
The rationale for an acute heart failure syndromes clinical trials networkSean P Collins, Phillip D Levy, Christopher J Lindsell, et al.
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Science (New York, N.Y.)|May 15, 2025
Deliberate extinction by genome modification: An ethical challengeGregory E Kaebnick, James P Collins, Athmeya Jayaram, et al.
Frontiers in Oncology|February 4, 2021
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation TherapyMichael Carrasquilla, Michael L Creswell, Abigail N Pepin, et al.
Hypertension (Dallas, Tex. : 1979)|January 30, 2026
Galectin-1 Is a Marker but Not a Mediator of Heart Failure With Preserved Ejection FractionJean W Wassenaar, C Duncan Smart, Daniel J Fehrenbach, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2003
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptorAchim A Jungbluth, Elisabeth Stockert, H J Su Huang, et al.
Frontiers in Oncology|November 30, 2020
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate CancerNima Aghdam, Abigail N Pepin, Michael Creswell, et al.
Pageof 205